AC Immune (ACIU) Equity Ratio (2016 - 2024)
Historic Equity Ratio for AC Immune (ACIU) over the last 10 years, with Q4 2024 value amounting to 0.49.
- AC Immune's Equity Ratio fell 4466.97% to 0.49 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.49, marking a year-over-year decrease of 4466.97%. This contributed to the annual value of 0.49 for FY2024, which is 4466.97% down from last year.
- According to the latest figures from Q4 2024, AC Immune's Equity Ratio is 0.49, which was down 4466.97% from 0.88 recorded in Q4 2023.
- In the past 5 years, AC Immune's Equity Ratio ranged from a high of 0.91 in Q4 2022 and a low of 0.49 during Q4 2024
- Moreover, its 5-year median value for Equity Ratio was 0.89 (2021), whereas its average is 0.81.
- In the last 5 years, AC Immune's Equity Ratio surged by 242.92% in 2022 and then tumbled by 4466.97% in 2024.
- AC Immune's Equity Ratio (Quarter) stood at 0.9 in 2020, then fell by 1.69% to 0.89 in 2021, then grew by 2.43% to 0.91 in 2022, then fell by 3.32% to 0.88 in 2023, then tumbled by 44.67% to 0.49 in 2024.
- Its Equity Ratio stands at 0.49 for Q4 2024, versus 0.88 for Q4 2023 and 0.91 for Q4 2022.